Table 2.
Oncological treatment parameters.
| Parameter | Number (%) |
|---|---|
| Type of first-line treatment | n=338 |
| surgery | |
| alone | 197 (58.3) |
| + CT | 18 (5.3) |
| + RT | 22 (6.5) |
| CT | |
| alone | 84 (25.4) |
| + RT | 4 (1.2) |
| RT | |
| alone | 13 (3.3) |
| Type of first surgery | n=237 |
| conventional | 134 (56.6) |
| functional | 103 (43.4) |
| Postoperative tumor volume | n=237 |
| ≥ 10 cm3 | 31 (18.2) |
| < 10 cm3 | 105 (61.8) |
| no residual tumor | 34 (20) |
| NA | 67 |
| Type of first chemotherapy | n=274 |
| TMZ | 213 (77.8) |
| PCV | 47 (17.2) |
| FTM | 9 (3.2) |
| BCNU | 5 (1.8) |
| Moment of radiotherapy | n=167 |
| early | 40 (23.9) |
| delayed | 96 (57.5) |
| after anaplastic transformation | 31 (18.6) |
CT, chemotherapy; RT, radiotherapy; TMZ, Temozolomide; PCV, procarbazine-CCNU-vincristine; FTM, fotemustine; BCNU, carmustine; NA, data non available at the time of the study.